“pancreatic-cancer” Archives

in
Entry Author Date Location
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
Five Prime, Bristol Pancreatic Cancer Drug Combo Fails Phase 2 Test 02/18/20 San Francisco
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
With $9.5M, Intrepida Bio Launches to Target Pancreatic Cancer & More 11/04/19 San Diego
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3 11/04/19 San Diego
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test 10/16/19 Indiana
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
Five Prime’s Shakeup Cuts Staff 20%, Keeps Focus on Clinical Programs 01/15/19 San Francisco
With Losses Mounting, MabVax Therapeutics Looks to Sell Off Assets 12/15/18 San Diego
OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma 12/05/18 San Francisco
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines 05/10/18 Indiana
With IPO, BioXcel Looks to Fund AI-Fueled Drug Discovery Work 02/14/18 New York
VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M 11/29/17 Boston
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos 11/07/17 San Francisco
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
Page 1 of 3 next page »